Global Nimodipine Market Outlook 2016-2021

Published: Sep, 2016 | Pages: 101 | Publisher: Gen Consulting Company
Industry: Pharmaceutical | Report Format: Electronic (PDF)

Nimodipine (marketed by Bayer as Nimotop) is a dihydropyridine calcium channel blocker originally developed for the treatment of high blood pressure. It is not frequently used for this indication, but has shown good results in preventing a major complication of subarachnoid hemorrhage (a form of cerebral hemorrhage) termed vasospasm.

Because it has some selectivity for cerebral vasculature, nimodipine's main use is in the prevention of cerebral vasospasm and resultant ischemia, a complication of subarachnoid hemorrhage (a form of cerebral bleed), specifically from ruptured intracranial berry aneurysms irrespective of the patient's post-ictus neurological condition. Its administration begins within 4 days of a subarachnoid hemorrhage and is continued for three weeks. If blood pressure drops by over 5%, dosage is adjusted. There is still controversy regarding the use of intravenous nimodipine on a routine basis.

A 2003 trial (Belfort et al.) found nimodipine was inferior to magnesium sulfate in preventing seizures in women with severe preeclampsia. Nimodipine is not regularly used to treat head injury. Several investigations have been performed evaluating its use for traumatic subarachnoid hemorrhage; a systematic review of 4 trials did not suggest any significant benefit to the patients that receive nimodipine therapy.

This report provides detailed analysis of worldwide markets for Nimodipine from 2011-2015 and provides extensive market forecasts 2016-2021 by region/country and subsectors. It covers the key technological and market trends in the Nimodipine market and further lays out an analysis of the factors influencing the supply/demand for Nimodipine, and the opportunities/challenges faced by industry participants. It also acts as an essential tool to companies active across the value chain and to the new entrants by enabling them to capitalize the opportunities and develop business strategies.

GCC's report, Global Nimodipine Market Outlook 2016-2021, has been prepared based on the synthesis, analysis, and interpretation of information about the global Nimodipine market collected from specialized sources. The report covers key technological developments in the recent times and profiles leading players in the market and analyzes their key strategies. The competitive landscape section of the report provides a clear insight into the market share analysis of key industry players. The major players in the global Nimodipine market are Bayer (Germany), Uquifa (Spain), Shandong Health (China), Ruikang Pharma (China), Kelun Group (China), Xinhua Pharmaceutical (China), Yabao Group (China), Central Pharm (China), among others.

The report provides separate comprehensive analytics for the North America, Europe, Asia-Pacific, Middle East and Africa and Rest of World. In this sector, global competitive landscape and supply/demand pattern of Nimodipine industry has been provided.

 Table of Contents

Part 1. Scope of Report
1.1 Methodology
1.2 Geographic Scope
1.3 Years Considered

Part 2. Introduction
2.1 Definition
2.2 Current Scenario
2.2 Future Scenario

Part.3 Value Chain Analysis
3.1 Upstream
3.2 Downstream

Part 4. Manufacture
4.1 Manufacturing Process
4.2 Issues and Trends
4.3 Manufacturing Costs

Part 5. Worldwide Key Vendors
5.1 Company A
5.1.1 Business Overview
5.1.2 Products Offered
5.1.3 Business Performance
5.2 Company B
5.3 Company C
5.4 Company D
5.5 Company E
5.6 Company F
5.7 Company G
5.8 Company H
5.9 Company I
5.10 Company J

Part 6. Market Overview
6.1 Global Production Volume 2011-2016
6.2 Production Volume by Region 2011-2016
6.2.1 North America
6.2.2 EMEA
6.2.3 Asia-Pacific
6.2.4 ROW
6.3 Global Production Value 2011-2016
6.4 Production Value by Region
6.4.1 North America
6.4.2 EMEA
6.4.3 Asia-Pacific
6.4.4 ROW

Part 7. Consumption Pattern
7.1 Regional Consumption
7.1.1 North America
7.1.2 EMEA
7.1.3 Asia-Pacific
7.1.4 ROW
7.2 Global Consumption by Application

Part 8. Market Forecast
8.1 Market Size by Volume
8.1.1 North America
8.1.2 EMEA
8.1.3 Asia-Pacific
8.1.4 ROW
8.2 Market Size by Value
8.2.1 North America
8.2.2 EMEA
8.2.3 Asia-Pacific
8.2.4 ROW
8.3 Regional Consumption Forecast
8.3.1 North America
8.3.2 EMEA
8.3.3 Asia-Pacific
8.3.4 ROW
8.4 Consumption Forecast by Application

Part 9. Market Dynamics
9.1 Market Drivers
9.2 Market Constraints
9.3 Market Strategies

Part 10. Key Events
10.1 Mergers & Acquisitions
10.2 New Product Launches
10.3 Expansions
10.4 Other Developments

List of Tables and Figures


Figure Global Nimodipine Production Volume (Unit) 2011-2016
Figure Global Nimodipine Production Value (M USD) 2011-2016
Figure Top 10 Nimodipine Vendors Production Volume Share 2015
Figure Top 10 Nimodipine Vendors Production Value Share 2015
Figure Regional Nimodipine Production (Unit) 2015
Figure Regional Nimodipine Production Value (M USD) 2015
Table Raw Material Materials Suppliers
Figure Global Nimodipine Consumption Pattern 2015
Figure Manufacturing Cost Structure
Figure Company A Nimodipine Products
Table Company A Financial Performance 2011-2016
Figure Company A Market Share 2011-2016
Figure Company B Nimodipine Products
Table Company B Financial Performance 2011-2016
Figure Company B Market Share 2011-2016
Figure Company C Nimodipine Products
Table Company C Financial Performance 2011-2016
Figure Company C Market Share 2011-2016
Figure Company D Nimodipine Products
Table Company D Financial Performance 2011-2016
Figure Company D Market Share 2011-2016
Figure Company E Nimodipine Products
Table Company E Financial Performance 2011-2016
Figure Company E Market Share 2011-2016
Figure Company F Nimodipine Products
Table Company F Financial Performance 2011-2016
Figure Company F Market Share 2011-2016
Figure Company G Nimodipine Products
Table Company G Financial Performance 2011-2016
Figure Company G Market Share 2011-2016
Figure Company H Nimodipine Products
Table Company H Financial Performance 2011-2016
Figure Company H Market Share 2011-2016
Figure Company I Nimodipine Products
Table Company I Financial Performance 2011-2016
Figure Company I Market Share 2011-2016
Figure Company J Nimodipine Products
Table Company J Financial Performance 2011-2016
Figure Company J Market Share 2011-2016
Table Global Key Nimodipine Vendors Production (Unit) 2011-2016
Table Global Key Nimodipine Vendors Production Share 2011-2016
Figure Global Nimodipine Capacity & Production (Unit), Capacity Utilization 2011-2016
Figure Global Top 10 Nimodipine Vendors Production (Unit) 2011-2016
Table Global Top 10 Nimodipine Vendors Production (Unit) 2011
Table Global Top 10 Nimodipine Vendors Production (Unit) 2012
Table Global Top 10 Nimodipine Vendors Production (Unit) 2013
Table Global Top 10 Nimodipine Vendors Production (Unit) 2014
Table Global Top 10 Nimodipine Vendors Production (Unit) 2015
Table Global Top 10 Nimodipine Vendors Production (Unit) 2016
Figure Nimodipine Production Volume (Unit) 2011-2016
Table Global Production Volume (Unit) 2011-2016
Table Global Production Volume Share 2011-2016
Figure North America Nimodipine Capacity & Production (Unit)
Figure North America Production Share Trend
Figure EMEA Nimodipine Capacity & Production (Unit)
Figure EMEA Production Share Trend
Figure Asia-Pacific Nimodipine Capacity & Production (Unit)
Figure Asia-Pacific Production Share Trend
Figure ROW Nimodipine Capacity & Production (Unit)
Figure ROW Production Share Trend Change
Figure Global Nimodipine Production Value (M USD), Growth Rate
Table Global Key Nimodipine Vendors Production Value (M USD) 2011-2016
Table Global Key Nimodipine Vendors Production Value Share 2011-2016
Figure Global Top 10 Nimodipine Vendors Production Value (M USD) 2011-2016
Table Global Top 10 Nimodipine Vendors Production Value (M USD) 2011
Table Global Top 10 Nimodipine Vendors Production Value (M USD) 2012
Table Global Top 10 Nimodipine Vendors Production Value (M USD) 2013
Table Global Top 10 Nimodipine Vendors Production Value (M USD) 2014
Table Global Top 10 Nimodipine Vendors Production Value (M USD) 2015
Table Global Top 10 Nimodipine Vendors Production Value (M USD) 2016
Figure Nimodipine Prices (USD/Ton) 2016
Figure Nimodipine Gross Margin 2016
Figure Nimodipine Production Value (M USD) By Region 2011-2016
Table Global Nimodipine Production Value (M USD) 2011-2016
Table Global Nimodipine Production Value Share 2011-2016
Figure North America Production Value (M USD), Growth Rate
Figure North America Nimodipine Production Value Share Trend
Figure EMEA Production Value (M USD), Growth Rate
Figure EMEA Nimodipine Production Value Share Trend
Figure Asia-Pacific Production Value (M USD), Growth Rate
Figure Asia-Pacific Nimodipine Production Value Share Trend
Figure ROW Production Value (M USD), Growth Rate
Figure ROW Nimodipine Production Value Share Trend
Figure Global Nimodipine Consumption Volume (Unit) 2015
Table Regional Nimodipine Consumption Volume (Unit) 2011-2016
Table Regional Nimodipine Consumption Volume Share 2011-2016
Figure Nimodipine Consumption in North America 2011-2016
Figure Nimodipine Consumption in EMEA 2011-2016
Figure Nimodipine Consumption in Asia-Pacific 2011-2016
Figure Nimodipine Consumption in ROW 2011-2016
Figure Global Nimodipine Consumption Volume (Unit) 2016
Table Global Nimodipine Consumption Volume (Unit) 2011-2016
Table Global Nimodipine Consumption Volume Share 2011-2016
Figure Global Nimodipine Production (Unit) Forecast 2016-2021
Table Global Nimodipine Production (Unit) 2016-2021
Table Global Nimodipine Production Share 2016-2021
Figure North Nimodipine Production (Unit) Forecast 2016-2021
Figure EMEA Nimodipine Production (Unit) Forecast 2016-2021
Figure Asia-Pacific Nimodipine Production (Unit) Forecast 2016-2021
Figure ROW Nimodipine Production (Unit) Forecast 2016-2021
Figure Global Nimodipine Revenue (M USD) Forecast 2016-2021
Table Global Nimodipine Revenue (M USD) 2016-2021
Table Global Nimodipine Revenue Share 2016-2021
Figure North America Nimodipine Revenue (M USD) Forecast 2016-2021
Figure EMEA Nimodipine Revenue (M USD) Forecast 2016-2021
Figure Asia-Pacific Nimodipine Revenue (M USD) Forecast 2016-2021
Figure ROW Nimodipine Revenue (M USD) Forecast 2016-2021
Figure Global Nimodipine Consumption Volume (Unit) 2016-2021
Table Global Nimodipine Consumption Volume (Unit) 2016-2021
Table Global Nimodipine Consumption Volume Share 2016-2021
Figure North America Nimodipine Consumption (Unit) Forecast
Figure EMEA Nimodipine Consumption (Unit) Forecast
Figure Asia-Pacific Nimodipine Consumption (Unit) Forecast
Figure ROW Nimodipine Consumption (Unit) Forecast
Figure Global Nimodipine Consumption Volume (Unit) 2021
Table Global Nimodipine Consumption Volume (Unit) 2016-2021
Table Global Nimodipine Consumption Volume Share 2016-2021
Table Key Strategies for Nimodipine Multinational Corporations
Table Key Strategies for Nimodipine Emerging-Market Players